title: Variability in the generation of induced pluripotent stem cells: importance for disease modeling.
abstract: In the field of disease modeling, induced pluripotent stem cells (iPSCs) have become an appealing choice, especially for diseases that do not have an animal model. They can be generated from patients with known clinical features and compared with cells from healthy controls to identify the biological bases of disease. This study was undertaken to determine the variability in iPSC lines derived from different individuals, with the aim of determining criteria for selecting iPSC lines for disease models. We generated and characterized 18 iPSC lines from eight donors and considered variability at three levels: (a) variability in the criteria that define iPSC lines as pluripotent cells, (b) variability in cell lines from different donors, and (c) variability in cell lines from the same donor. We found that variability in transgene expression and pluripotency marker levels did not prevent iPSCs from fulfilling all other criteria for pluripotency, including teratoma formation. We found low interindividual and interclonal variability in iPSCs that fulfilled the most stringent criteria for pluripotency, with very high correlation in their gene expression profiles. Interestingly, some cell lines exhibited reprogramming instability, spontaneously regressing from a fully to a partially reprogrammed state. This was associated with a low percentage of cells expressing the pluripotency marker stage-specific embryonic antigen-4. Our study shows that it is possible to define a similar "ground state" for each cell line as the basis for making patient versus control comparisons, an essential step in order to identify disease-associated variability above individual and cell line variability.
authors.affiliation: Griffith University, Brisbane, Queensland, Australia.
authors.forename: Alejandra M
authors.initials: AM
authors.lastname: Vitale
authors.forename: Nicholas A
authors.initials: NA
authors.lastname: Matigian
authors.forename: Sugandha
authors.initials: S
authors.lastname: Ravishankar
authors.forename: Bernadette
authors.initials: B
authors.lastname: Bellette
authors.forename: Stephen A
authors.initials: SA
authors.lastname: Wood
authors.forename: Ernst J
authors.initials: EJ
authors.lastname: Wolvetang
authors.forename: Alan
authors.initials: A
authors.lastname: Mackay-Sim
mesh_terms: D000328:Adult; D000818:Animals; D015415:Biomarkers / Q000032:analysis; D002454:Cell Differentiation; D002460:Cell Line; D002478:Cells, Cultured; D065150:Cellular Reprogramming; D005260:Female; D005347:Fibroblasts; D020869:Gene Expression Profiling; D014644:Genetic Variation; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000502:physiology*; D008297:Male; D051379:Mice; D008875:Middle Aged; D012559:Schizophrenia; D013724:Teratoma; D055815:Young Adult
chemical_list: D015415:Biomarkers